Vivaldi Biosciences Inc.

One company’s growth-leader is another’s undesirable diversification – that’s the takeaway from the July 30 transaction in which Pfizer Inc. purchased Baxter International Inc. ’s vaccines busi

IN VITRO DIAGNOSTICS Mergers & Acquisitions Clinical Genomics Technologies Pty. Ltd. Quest Diagnostics Inc. Enterix Inc. As part of a continued effort to focus on its Diagnostics Information Services

Dyax prices $60m offering; MacroGenics surges in first day of trading; Vivaldi acquires vaccine assets; and Rexahn licenses academic drug delivery platform. Dyax stock sees small dip then gains as co

The biotechnology industry is looking forward to offering its views against universal purchase for vaccines to a Colorado task force that would be set up to explore immunization access under state leg